Maillard reaction inhibitor

Details Maillard reaction inhibitor Maillard reaction inhibitor

1995-08-15

1997-04-15

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heavy metal containing doai

A61K 3128

Patent

active

056210035

ABSTRACT:
A maillard reaction inhibitor comprising, as the principal component, an eight-structural polymer of 3-oxygermylpropionic acid represented by the following stereostructure (I): ##STR1## wherein R represents --CH.sub.2 CH.sub.2 COOH, and m is a weight average polymerization degree calculated on the basis of the weight average molecular weight of propagermanium propyl ester and is 137.+-.84 (137 on average with a standard deviation of .+-.3.sigma.); and having the following minimum constitutional unit:

REFERENCES:
patent: 4889715 (1989-12-01), Sawai et al.
patent: 5008416 (1991-04-01), Kurone et al.
patent: 5240700 (1993-08-01), Sawai et al.
patent: 5260056 (1993-11-01), Sawai et al.
patent: 5279835 (1994-01-01), Sawai et al.
patent: 5336688 (1994-08-01), Sawai et al.
patent: 5340806 (1994-08-01), Sawai et al.
Tokuda et al, Yakuri/Pharmacometrics, 46(1):39-43 (1993).
The Washington Post (Feb., 1995).
AIDS, 8(1):561-569 (1994).
Sternbert, BioWorld Today, 6(22):1-5 (1995).

Affiliated with

Also associated with

Rating

Maillard reaction inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Maillard reaction inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Maillard reaction inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-361158